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Abstract
A core set of standardized balance measures are required for use in 
rehabilitation among people with multiple sclerosis (MS) and cerebellar ataxia. 
An earlier systematic review and Delphi survey identified the Berg Balance 
Scale (BBS), the Timed Up and Go test (TUG), Posture and Gait sub-component 
of the International Co-operative Ataxia Rating Scale (PG of ICARS) and the 
gait, sitting and stance sub-components of the Scale for the Assessment and 
Rating of Ataxia (SARA Bal) as suitable balance measures. This study aims 
to estimate the reliability, validity and interpretability of these measures. This 
study will recruit 60 participants with multiple sclerosis with secondary cerebellar 
involvement across four centres in New Zealand and the United States of 
America. Participants will be assessed and videotaped performing the BBS, 
TUG, SARA Bal and PG of ICARS by trained physiotherapists. Barthel Index, 
Expanded Disability Status Scale (EDSS), Disease duration, ICARS and SARA 
will also be assessed to determine validity. A second assessment to determine 
reliability will be conducted by assessors watching the video-recording. Data 
collection is in progress, 44 samples have been collected and the demographic 
data are presented. The findings of this study will recommend a core set of 
reliable, valid and interpretable measures that are suitable for clinical practice 
and research for the assessment of balance among adults with MS and 
cerebellar ataxia. Minimal Clinically Important Difference (MCID) and cut-off 
scores to predict the use of assistive walking device will be established.  
Keywords: Study protocol; Reliability; Validity; Multiple sclerosis and 
Cerebellar ataxia
Abbreviations
BBS: Berg Balance Scale; COSMIN: COnsensus based Standards 
for the selection of health status Measurement INstrument; EDSS: 
Expanded Disability Status Scale; ICC: Intra class Correlation Co-
efficient; MCID: Minimally Clinical Important Difference; MS: 
Multiple Sclerosis; NZ: New Zealand;  PG of ICARS- Posture and 
Gait sub-component of the International Co-operative Ataxia Rating 
Scale; SARA Bal: gait, stance and sit sub-components of the Scale for 
the Assessment and Rating of Ataxia; TUG: Timed Up and Go test; 
USA: United State of America; α: Cronbach’s alpha.
Introduction
Multiple sclerosis (MS) is a progressive, demyelinating disorder 
of the central nervous system resulting in a wide spectrum of clinical 
symptoms that include physical and cognitive impairments [1]. MS 
has a global prevalence ranging between 200 per 100,000 to very 
rare cases in some countries [2, 3]. New Zealand (NZ) has an overall 
prevalence of 73.1/100,000 of people diagnosed with MS, and that 
prevalence increases three-fold in the South Island [4] raising to 
134.6/100000 [5]. The United States of America (USA) has a prevalence 
of 90 / 100,000 [6]. Up to 80% of people with MS experience ataxia 
at some point in the disease course [7]. Demyelination due to MS 
involves multiple areas of the brain and it may be difficult to localize 
the lesion based on the presenting symptoms. However, ataxia, limb 
dyskinesia and postural tremor occurring in MS are believed to be 
Research Article
Balance Assessment in Multiple Sclerosis and Cerebellar 
Ataxia: Rationale, Protocol and Demographic Data
Winser S1*, Smith CM1, Hale LA1, Claydon LS2, 
Whitney S3,4, Klatt B3, Mottershead J5, Zaydan I6 
and Heyman R6
1Centre for Health, Activity and Rehabilitation Research, 
School of Physiotherapy, University of Otago, New 
Zealand 
2Department of Allied Health and Medicine, Anglia 
Ruskin University, UK 
3School of Health and Rehabilitation Sciences, University 
of Pittsburgh, USA  
4Rehabilitation Research Chair at King Saud University, 
Saudi Arabia 
5Dunedin School of Medicine, Neurology, University of 
Otago, New Zealand 
6School of Medicine, Neurology, University of Pittsburgh, 
USA
*Corresponding author: Stanley Winser, Centre for 
Health, Activity and Rehabilitation Research, School of 
Physiotherapy, University of Otago, New Zealand
Received: November 11, 2014; Accepted: November 
20, 2014; Published: November 25, 2014
due to lesions of the cerebellum and its connections [8]. Cerebellar 
ataxia secondary to MS presents with one or more of the following 
symptoms: ataxia (both limb and gait), nystagmus, disequilibrium, 
dysarthria and hypotonia [9].
Cerebellar ataxia itself is not a disease but an ‘umbrella’ term that 
includes multiple diseases with lesions localized to the cerebellum. 
Choosing an appropriate measure for the assessment of balance in 
cerebellar ataxia is challenging as there is no recommended set of 
tools, yet a wide range of measures are currently used for interventions 
and identification or illustration of clinical features relating to balance 
and postural control [10]. Current guidelines focus on treatment 
strategies to improve balance and gait in people with cerebellar ataxia, 
and little emphasis has been placed on the optimal use of measures of 
balance [7, 11, 12]; only one international guideline [13] reports on 
best clinical practice for the intervention and assessment of balance 
in people with cerebellar ataxia and present a list of 13 measures of 
balance that are commonly used in clinical practice. The diversity of 
measures of balance used in published information is not helpful to 
derive at a core set of standardized measures of balance among people 
with cerebellar ataxia. It would be useful to determine how many of 
the measures used in literature are appropriate for the assessment of 
balance among the target group. Interestingly, a systematic review 
that evaluated the effects of physiotherapy treatment options for 
cerebellar ataxia reports the lack of use of valid and reliable outcome 
measures to estimate treatment benefits [14]. 
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Frequently used balance measures in the clinical setting for people 
with cerebellar ataxia are: Single leg stance [15], Tandem standing [16], 
Standing with eyes closed (Romberg’s test) [17], Walking in a straight 
line (Tandem Walking), Walking along around a circle, Functional 
Reach Test [18] and External perturbation test [15]. Although these 
functional measures provide useful information on changes in 
balance, their psychometric properties and appropriateness for the 
assessment of balance is not known. 
Earlier research to identify a core set of standardized measures of 
balance among people with cerebellar ataxia comprised a systematic 
review and a Delphi survey. The systematic review identified the 
Posture and gait sub-component of the International Co-operative 
Ataxia Rating Scale (PG of ICARS) as an appropriate measure because 
of its favorable psychometric properties [19]. The Delphi survey asked 
neurologists and physiotherapists specialized in treating people with 
cerebellar ataxia about clinically useful measures. The outcomes of 
the survey indicated the Berg Balance Scale (BBS), Timed up and go 
(TUG) test and the gait, stance and sit sub-components of the Scale 
for the Assessment and Rating of Ataxia (SARA Bal) as recommended 
measures of balance [20]. In order to strengthen recommendations 
for use of these four measures of balance in clinical practice, further 
validation is required. Due to the high prevalence of MS in NZ and 
USA, people with MS and secondary cerebellar involvement will be 
recruited and tested for this validation. 
The aims of this study are to estimate the reliability, validity and 
interpretability of the BBS, TUG, PG of ICARS and SARA Bal among 
people with MS and secondary cerebellar ataxia. The specific aims of 
this study are (1) To estimate the internal consistency, intra-rater and 
inter-rater reliability of the four measures of balance, (2) To estimate 
the criterion, convergent, external and predictive validity of the 
measures of balance, (3) Determine the cut-off scores, sensitivity and 
specificity for the measures to discriminate between assistive walking 
device users and non-users and (4) To derive the Minimally Clinical 
Important Difference (MCID) for the four measures of balance.
Materials and Methods 
The study is registered with the Australia New Zealand Clinical 
Trials Registry (Ref: ACTRN12613000079741) and ethical clearance 
has been obtained from the University of Otago Human Ethics 
Committee (Ref: 13/041), NZ and Institutional Review Board (IRB), 
The Multiple Sclerosis and Related Disorders Research Registry (Ref: 
PRO12010609 ) USA.
A cross sectional methodological observation study is proposed. 
As recommended by the COnsensus based Standards for the selection 
of health status Measurement INstrument (COSMIN) checklist for 
‘good’ quality research, a sample size of 50 is required [21] and 
this study aims for a sample size of 60. The data will be collected in 
three centres across NZ and one centre in the USA.  People with MS 
and secondary cerebellar involvement will be recruited if they are: 
aged between 18 and 65 years, people with a definite diagnosis of 
MS presenting with at least one of the following clinical cerebellar 
symptoms: gait ataxia, limb ataxia - identified by dysdiadochokinesia 
and dysmetria, dysarthria, nystagmus and they are able to walk at 
least 10m with or without the use of assistive aids. Exclusion criteria 
include people with inability to follow simple commands, severe 
visual impairment, Expanded Disability Status Scale (EDSS) score > 
6.5 and those who do not give permission for the research team to 
access to their medical record.
Procedure
The investigators will screen the volunteer for eligibility. All 
participants will be assessed on one occasion that will last for 60 
minutes. The following measures will be assessed during this visit: 
(1) The BBS, (2) The TUG, (3) PG of ICARS and (4) the SARA Bal. 
The assessment process will be video-recorded (detailed below). 
The order of balance assessment tests is kept constant as follows: 
BBS, PG of ICARS, TUG and SARA Bal. The participants are split 
equally and the order of assessment is reversed (SARA Bal to BBS), 
in order to neutralise the influence of fatigue on the measure that is 
assessed last during the session. In addition, the Barthel Index, and 
full scales of ICARS and SARA will be scored by the investigators 
during the assessment session. These scales will be used to derive the 
constructs of validity. The EDSS score will be either retrieved from the 
participant’s medical record or a separate appointment is arranged 
with the neurologist for this evaluation.
A video-recording of the four measures of balance (BBS, TUG, 
PG of ICARS and SARA Bal) will be performed using a wide angle 
digital video for each participant during the appointment. Sony 3.3 
Mega Pixels handycam is being used for the video recording, in order 
to enhance a wide angle capture a Sony wide end conversion lens × 0.8 
is fitted to the camera lens. Research assistants are appointed to assess 
and video shoot the proceedings in both countries. To standardize the 
video recording across the study centres, a ‘Standard video recording 
protocol’ was developed by the research team and distributed among 
the investigators. The following points are emphasised in the ‘Standard 
video recording protocol’: the order of measures, instructions to 
the participants, equipment used for the assessment (thickness of 
mattress, height of chair, height of foot stool, use of footwear of the 
participant etc.), angle(s) of video recording, and the lighting of the 
assessment area. The ‘Standard video recording protocol’ minimises 
the potential inconsistencies in the above-mentioned factors that are 
crucial for obtaining an accurate reliability and validity estimate. After 
recording a test session, the video data will then be transcribed onto a 
DVD and distributed among the other members of the research team. 
The data from the USA will be transferred to NZ through Secure Zip, 
a password-enabled data transfer software. The video recordings will 
be used in this study to evaluate constructs of reliability. 
Below, the first assessment done by the investigators on 
participants is called the ‘Live assessment’, and the repeat assessment 
done by same investigatorfrom the video recording is called ‘Video 
assessment 1’. The repeat assessment done by the second investigator 
from the same video recording is identified as ‘Video assessment 2’. 
The flow of this study is outlined in Figure 1.
Psychometric properties tested 
(Definitions adopted with permission from COSMIN manual 
[22].)
Intra-rater reliability:  Defined as the proportion of variation in 
the scores of the participant done by the same assessor with an interval 
of 7-10 days. Variation between the live assessment scores and the 
scores of video assessment 1 will be compared. Video assessment 1 
is the repeat assessment done by the same rater observing the video 
recording 7-10 days later. 
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Inter-rater reliability: Defined as the proportion of variation 
in the scores of the participant done by two different assessors. 
Variation between the scores of the live assessment and the scores of 
video recording 2 will be compared. The second rater will assess by 
observing the video recording. 
Internal consistency: Defined as the degree of interrelatedness 
between the test items, internal consistency will be calculated for each 
measure separately.
Criterion validity: This is defined as the degree to which the 
scores of the measure under investigation are an adequate reflection 
of a ‘gold standard’. Since a ‘gold standard’ is currently not available 
for balance assessment for people with MS with cerebellar ataxia, 
or those with other types of cerebellar ataxia, the measures will be 
correlated between each other. 
Hypothesis testing: Defined as the degree to which the scores of 
the measures under investigation are consistent with the hypotheses 
(for instance, with regard to internal relationships, relationships to 
scores of other instruments, or differences between relevant groups), 
this is based on the assumption that the instrument validly measures 
the construct to be measured. The following hypotheses will be tested:
•	 Correlation between balance measures and ataxia rating 
scales (ICARS and SARA) - Convergent validity
•	 Correlation between balance measures and MS disease 
staging score (EDSS) - External validity
•	 Correlation between balance measures and functional 
independence (Barthel Index) - External validity
Predictive validity: Defined as the ability of the balance measures 
to differentiate between assistive walking device users and non-users, 
this will be determined by observing the group difference for the 
measures of balance. The cut-off score, sensitivity, and specificity of 
the measures of balance to discriminate between the groups will be 
identified.
Interpretability
MCID: This may be defined as the smallest difference a patient 
would perceive as beneficial as a result of the treatment [23]. The 
MCID will be established using the data driven method. 
Measures considered
The BBS is a five point ordinal scale with 14 tasks that are each 
scored between 0 and 4, with the highest score of 56. This measure 
is interpreted as better balance with higher scores [24]. This measure 
has good inter-rater (ICC=0.96) and test retest (ICC=0.94) reliability 
[25, 26]. Acceptable concurrent validity in assessing balance among 
people with MS has been reported [27].
The TUG is a measure of an individual’s dynamic stability and 
can predict falls risk. The TUG measures the time taken in seconds 
to arise from a chair, walk 3 meters, turn through 180 degrees and 
return to the seat [28]. A longer completion time indicates a higher 
risk of falling. The TUG has good test retest reliability (ICC=0.94) 
[26], moderate correlation with other clinical measures of balance, 
and an acceptable concurrent validity in assessing balance among 
people with MS [27].
The SARA is an ataxia rating scale. It consists of eight items 
among which the gait, sitting, and standing subcomponents are 
related to balance assessment. The three sub-components are scored 
out of 18 and called SARA Bal. The higher the score obtained, more 
severe the ataxia. SARA has high internal consistency (α >0.85) 
among the test items [29], very high inter rater (ICC>0.80) [30], 
intra rater (ICC>0.86) [31] and test retest reliability (ICC>0.91) [29]. 
Structural validity has been reported [32], satisfactory convergent 
validity when correlated with other ataxia rating scales [32], and 
adequate responsiveness has been demonstrated [33]. These tests 
have been conducted among both genetic and acquired forms of 
cerebellar diseases.
ICARS is a measure of ataxia severity and consists of 19 items 
categorised as 1: Posture and gait disturbances; 2: Kinetic function; 3: 
Speech disorders and 4: Oculomotor disorders. The posture and gait 
sub-component relates to balance assessment. A participant can score 
a maximum of 100, with a higher score denoting more severe ataxia. 
The posture and gait sub-component is scored out of 34. The ICARS 
has excellent intra rater (ICC=0.96) and test retest (ICC=0.96) [34] 
reliability and high internal consistency (α= 0.93). Structural validity 
has been estimated [35]. The measure has adequate criterion validity 
[36] and good responsiveness [37]. The psychometric property 
testing has been used in a wide spectrum of diseases with cerebellar 
involvement. 
The Barthel Index is an ordinal scale used to measure 
performance in activities of daily living (ADL). This scale rates the 
performance of ten items relating to ADL and mobility. Each item 
is scored between 0 and 15. The higher the score obtained, the better 
the functional independence. The scale has a total of 100 points and 
a minimum of 0. The Barthel Index has adequate to excellent inter-
rater reliability (kappa values between 0.53 and 0.94) and excellent 
internal consistency (α= 0.89) among people with acute stroke 
[38]. The scale has excellent criterion [39] and construct validity in 
assessing functional independence among people with stroke, head 
injury and MS [40].
Patients screened 
in NZ (n=220)
Participants 
included (n=6) 
Volunteers from 
USA (n=6) 
Total sample size 
(n=50) 
Live assessment 
(n= ) 
Video assessment 
1 (n= ) 
Fresh EDSS 
assessments (n= ) 
Video assessment 
2 (n= ) 
Lost data 
(n= ) 
 
Excluded: 
Age(n=24) 
Not walking (n=7) 
No ataxia (n=106) 
Wrong ID (n=3) 
Others (n=7) 
 
Participants 
included (n=44) 
ipants 
included (n=xx) 
Patie ts screened 
in USA (n=xx) 
l sa ple size 
(n= ) 
Fresh EDSS 
assessments (n=8) 
Excluded: 
 
Figure 1: Flow chart for data collection.
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The EDSS is a scale used to quantify disability in people with MS. 
There are eight functional systems that are scored using the Functional 
System Score (FSS). Based on the FSS scores and on ambulation, the 
EDSS is scored between 0 to 10 each grade rising in 0.5 increments 
except between the stages 0 and 1. The higher scores suggest greater 
disability due to MS. The EDSS demonstrates adequate inter–rater 
reliability (ICC=0.78), variable intra-rater reliability (ICCs between 
0.62 and 0.94), and adequate convergent and discriminant validity 
among people with MS [41].
Current status of the study
Data collection at NZ is complete and yielded 44 participants. The 
data collection at the USA is in progress and will continue till the end 
of December 2014 or until the total sample size reached 60.
Data analysis
Non-parametric tests will be used for the ordinal scales (BBS, 
ICARS, SARA, Barthel Index and EDSS) and parametric test will be 
applied to the one interval scale (TUG). The intra class correlation 
coefficient (ICC) with one way random model and absolute agreement 
will be used to determine intra-rater and inter-rater reliability, and 
Cronbach alpha (α) for internal consistency. The ICC and α will be 
interpreted as follows: <0.50 or >-0.50 as weak, those between 0.5 and 
0.79 or -0.5 and -0.79 as moderate, and those > 0.8 or <-0.8 as strong. 
Spearman correlation coefficient, bivariate analysis of a non-
parametric sample is used to establish constructs of validity. 
Correlation coefficients of <0.50 or >-0.50 will be interpreted as weak, 
those between 0.5 and 0.79 or -0.5 and -0.79 as moderate, and those 
> 0.8 or <-0.8 as strong. 
Group differences of scores between users and non-users of 
assistive walking devices will be considered for establishing predictive 
validity. The Mann-Whitney U Test will be used to determine 
group differences for the ordinal scales, and the independent t test 
for the TUG, as it is an interval scale. Further, a receiver operating 
characteristics (ROC) curve will be constructed to determine the cut 
off score, sensitivity, and specificity of the measures to discriminate 
the use of an assistive device. In addition to determine which measure 
had a better predictive ability, the ‘area under the curve’ (AUC) of 
the ROC will be examined. The MCID will be estimated using a data 
driven method proposed by Werwich et.al [42, 43]. The Cronbach 
alpha of the measures of balance will be used to estimate the Standard 
Error of Measurement (SEM) that reflected the MCID. 
The following formula was used to determine the MCID.
S1= standard error at baseline, rα= Cronbach’s alpha coefficient for 
internal consistency.
The computer program “Statistical Package for the Social 
Sciences” (SPSS) statistics version 20, will be used to analyse the data.
Results and Discussion
The demographic data of 44 participants from NZ are presented 
in Table 1. Two hundred and twenty patients with MS were screened. 
Of these, seventy-three were eligible for the study and the remainders 
were excluded for the following reasons: did not meet age criteria 
(n=24), was wheel chair or bed bound (n=7), no ataxia (n=106), 
incorrect NHI ID number (n=3), moved out of NZ (n=5), or deceased 
(n=2). Of the seventy-three eligible, 44 gave informed consent and 
were recruited to the study.
The mean age of participants was 48.5 years (SD±11.6), 33 (75 
%) were female, forty three (97.72%) were NZ Europeans and one 
(2.27%) was Māori. Nineteen participants (43.2 %) were employed 
and the rest were either unemployed or retired from work.  The mean 
duration of their disease was 12.1 (SD±10) years and the mean age 
at disease onset was 36.4 (SD±10.6) years. Twenty-nine participants 
(65.9 %) did not use an assistive device for ambulation and 15 
(34.1%) were assistive device users. Some of the assistive devices 
the participants used were: 1 stick (n=5), 1 elbow crutch (n=4), 2 
elbow crutches (n=2), 1 quadripod (four-legged cane) (n=1) and 
rollator (rolling walker) (n=3). Four assessments were performed at 
participant’s home and the remaining (n=40) took place at one of 
the research centres. EDSS assessments for eight participants were 
performed by a neurologist, and for the remaining 36 participants, 
their EDSS scores were retrieved from their medical records. Flow of 
data collection and the proposed scheme for psychometric property 
analysis can be found at Figure 1.
Characteristic Centre 1 (n =36 ) Centre 2 (n= 6) Centre 3 (n=2 ) Centre 4 (n=x ) Total (n=44)
Age (yr), Mean (SD)
(Range)
48.1 (11.7)
(21-65)
49.3 (12.7)
(27-59)
53 (8.4)
47 and 59
48.5 (11.6) 
21-65
Sex, number female (%) 29 (80.5) 2 (33.4) 2 (100) 33 (75)
Ethnicity n (%) 
NZ European    Māori
American
Others
36 (100) 
0 
0 
0
5 (83.3) 
1 (16.6) 
0 
0
2 (100) 
0 
0 
0
43 (97.7) 
1 (2.3) 
0 
0
Employment status n (%) Employed              Unemployed
16 (44.4) 
20 (55.5)
2 (83.3) 
4 (16.6)
1 (50) 
1 (50)
19 (43.2) 
25 (54.7)
Age at disease onset (yr),
mean (SD) and range
36.1 (10.5)
(19-52)
37.3 (13.3)
(21-52)
38.5 (2.1)
37 and 40
36.4 (10.6)
(21-52)
Disease duration (yr), mean (SD) and range 12 (8.9)(2-40)
12 (8.3)
(3-26)
14.5 (10.6)
(7 and 19)
12.1(10) 
(2-40)
Cerebellar ataxia signs
n (%)
Gait ataxia
Dysmetria 
Speech Nystagmus
13 (36.1) 
29 (80.5) 
20 (55.5) 
21 (58.3)
5 (83.3) 
5 (83.3) 
1 (16.6) 
4 (66.6)
2 (100) 
1 (50) 
1 (50) 
0
20 (45.5) 
35 (79.5) 
22 (50) 
25 (56.8)
Use of walking aids, n (%) Users Non-users
12 (33.3) 
24 (66.6)
1 (16.6) 
5 (83.3)
1 (50) 
1 (50)
14 (31.8) 
30 (68.1)
Table 1: Demographic characteristics of participants.
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The findings of this study will be the first to investigate and 
report on reliability, validity and interpretability of four measures 
of balance among participants with MS having secondary cerebellar 
involvement. The measures of balance included are two generic scales 
(BBS and TUG) and two cerebellar-specific scales (PG of ICARS and 
SARA Bal). 
Clinical Significance of the Findings
Finding evidence for the use of generic measures among people 
with cerebellar ataxia will be one of the key features of this study. 
Previous studies report the frequent use of generic measures by 
clinicians for the assessment of balance among people with cerebellar 
ataxia [20, 44]. However, the appropriateness of using these measures 
is unknown. The findings of this study will assist clinicians in 
choosing suitable generic measure that is psychometrically sound for 
the assessment of balance among the target population. 
Secondly, this is the first study to report MCID for the measures 
of balance. Since this study will not re assess participants following 
an intervention where arguably a change in score could be expected, 
a data driven method will be used to establish the MCID. The MCID 
to be established is a reflection of the standard error of measurement 
(SEM) for the measures of balance and could be considered as a 
“proxy” for the MCID. The term “proxy” in statistics refers to a 
value that is probably not in itself of any great interest, but from 
which a variable of interest can be obtained. Previous studies have 
found an excellent agreement between the MCID and one SEM on 
Chronic Heart Disease Questionnaire tested among people with 
cardiovascular diseases [43]. Therefore the derived MCID, will guide 
clinicians and researchers to report on the treatment effects from a 
clinical perspective in terms of a difference in score that is perceived 
as a health benefit by the patient.
Lastly, the derived cut-off scores may assist clinicians in making 
decisions on prescribing assistive devices for walking among people 
with MS and secondary cerebellar involvement. Assistive device 
use improves the persons balance, mobility and functional ability; 
facilitates a generalized wellbeing and in addition, reduces the decline 
of functional status and the burden of health care [45-47]. Therefore 
prescribing assistive device at the right time becomes critical. Since 
we aim to determine a cut-off score with high sensitivity (90%), one 
may rely on the measures of balance to effectively identify people who 
may require an assistive device. 
This study has several strengths that include, sample size adequate 
to fulfill ‘good’ quality research according to the COSMIN criteria, 
diversity of the geographic representation of participants, inclusion of 
neurologists to identify and assess disease severity of the participants, 
balance assessments performed  by qualified physiotherapists, use 
of the ‘Standardised video recording protocol’ to standardise the 
assessment across the study centres. Some of the disadvantages of 
the proposed methods are: the influence of fatigue on participants’ 
performance, lack of standardizing the time of assessment that may 
have influenced participants’ potential. MS is a condition that affects 
multiple systems, and although people were specifically recruited 
with cerebellar ataxia, it is likely that other systems may influence the 
presentation of balance dysfunction.
Conclusion
The findings of this study will have high relevance in that, 
recommendations on a standardized core set of measures for the 
assessment of balance among people with cerebellar ataxia will be 
proposed. In addition, this study will find evidence for the use of 
generic measures (BBS and TUG) among people with cerebellar 
ataxia and cerebellar-specific (PG of ICARS and SARA Bal) among 
people with MS and cerebellar ataxia. Values of high clinical relevance 
such as the MCID, cut-off scores, sensitivity and specificity will be 
reported.
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